Recent News : Bacteriophage technology could reduce Salmonella in poultry

-

Bacteriophage technology could reduce Salmonella in poultry

Viruses that kill specific bacteria, known as bacteriophages, are emerging as an alternative to antibiotics in poultry production.Pts25 297

Paul Ward | WATT Global Media
A platform that creates custom phage cocktails targeting Salmonella bacteria could help producers reduce disease in poultry flocks.

According to Hans Pieringer, CEO, PhageLab, the technology company created an algorithm that evaluates the genome of the bacteria to identify small differences and understand specific serotypes, antibiotic resistance and pathology, which helps create tailored solutions for producers.

Antibiotics may kill beneficial and harmful bacteria; however, the phage technology is able to only target specific pathogenic strains while preserving gut health. The technology helps address antimicrobial resistance and offers a targeted approach that maintains flock health without contributing to resistance problems, he said.

“Close to 50% of antimicrobials are useless right now and can’t significantly control bacterial outbreaks on farms," Pieringer stated during the 2025 Poultry Tech Summit held November 3-5, 2025, in Atlanta, Georgia.

The platform works by identifying the specific bacterial strains present on a farm, then selecting the most effective bacteriophages using an algorithm developed through artificial intelligence (AI) and 15 years of phage-bacteria interaction data. Within 45 days, the platform produces a custom cocktail of different phages that can be delivered through drinking water on the farm.

Additionally, the phage cocktails can evolve with changing bacterial populations, he continued. PhageLab updates its formulations every six months to prevent resistance and address new bacterial strains.

According to Pieringer, 170 million birds in the Brazilian poultry market were treated in 2024 using the phage platform. In a field study involving 60 million birds, a 23% reduction in Salmonella-positive flocks was achieved using the technology, Pieringer added.

While the technology is established in Brazilian poultry, PhageLab is looking for opportunities to partner with producers in the U.S.



Article taken from, copyright belongs to : https://www.wattagnet.com/2025-poultry-tech-summit-coverage/article/15774998/bacteriophage-technology-could-reduce-salmonella-in-poultry

Comments

Post a Comment

Popular posts from this blog

History Part 12 : Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s)

-
Image
Post-War Stagnation and Phage Therapy’s Marginalization in the West (1945–1980s) The period following World War II marked a decisive turning point in the trajectory of phage therapy in Western medicine. Despite the promising results bacteriophages had demonstrated prior to the war as potential antibacterial agents, the decades after 1945 saw a dramatic decline in interest, funding, and scientific engagement with phage therapy in the United States and much of Western Europe. This marginalization can be attributed to a confluence of scientific, sociopolitical, and economic factors that reshaped the landscape of infectious disease treatment and research. Artistic View One of the key contributors to this decline was the overwhelming optimism surrounding the newly discovered class of antibiotics. The post-war pharmaceutical revolution brought forward a series of broad-spectrum antibiotics such as streptomycin, tetracycline, and chloramphenicol, which were viewed as miracle drugs capable o...
Read more

The Phage Therapy in the spotlight !

-
Image
Bacteriophages: Ancient Predators and the Next Frontier in Medicine In the animated documentary The Deadliest Being on Planet Earth , the Kurzgesagt team delves into the world of bacteriophages—viruses that prey exclusively on bacteria. With vibrant visuals and precise narration, the video introduces viewers to an invisible ecosystem where microscopic hunters orchestrate life-and-death dramas that shape the biosphere. These entities, though virtually unknown to the general public, may soon become central to the future of medicine. At the heart of the video lies a paradox: bacteriophages (or "phages") are among the most abundant biological entities on Earth—outnumbering all other organisms combined—yet their therapeutic potential has been largely sidelined in the antibiotic era. The video outlines the historical trajectory of phage research, spotlighting Félix d’Hérelle’s early 20th-century work and the rise of phage therapy, only to show how it was later eclipsed by the dis...
Read more

Groundbreaking achievement : Phagos raises €25m to end bacterial disease

-
Image
 Phagos raises €25m to end bacterial disease  The company holds the first authorization to market personalized veterinary phage-based treatments on EU soil  ● Founded in 2021, Phagos is ushering in a new era in the fight against bacterial disease with bacteriophages, a powerful alternative to antibiotics. Thanks to an unprecedented regulatory breakthrough and a discovery platform combining microbiology and AI, Phagos offers the first phage-based drugs for veterinary use, a market worth tens of billions of dollars. The company plans to expand further as phage therapy becomes accepted in human health.                              ● The funding round was co-led by CapAgro, Hoxton Ventures, CapHorn, and Demeter alongside Acurio Ventures, Citizen Capital, Entrepreneur First, Founders Capital, and Station F.  ● Objectives: deploy veterinary treatments in the field, develop the next generation of pat...
Read more